Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ma-Spore ALL 2010 Study
NCT02894645Phase 4Unknown
- Sponsor
- National University Hospital
- Start
- Oct 2008
- Primary completion
- Oct 2018
- Modality
- Monoclonal Antibodies, Lipid-based Nanoparticles, Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 4 trial of prednisolone, dexamethasone, asparaginase escherichia coli, vincristine sulfate liposome injection, methotrexate in acute lymphoblastic leukemia (ALL), sponsored by National University Hospital. Status: unknown.
02
Drugs
prednisolonedexamethasoneasparaginase escherichia colivincristine sulfate liposome injectionmethotrexate
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT02894645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02894645.